Picture of Organon & Co logo

OGN Organon & Co Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Annual cashflow statement for Organon & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2019
December 31st
C2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3,3062,2561,3519171,023
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items-212-62498199180
Discontinued Operations
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-672-117702-452-155
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities2,7672,1872,458858799
Capital Expenditures-92-255-296-303-259
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-10-3-185-117-1
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-102-258-481-420-260
Financing Cash Flow Items-2,621-3,687-8,916-35-17
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,621-2,175-1,333-433-569
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash75-249667-31-13